Literature DB >> 16627962

The inflammatory tumor microenvironment and its impact on cancer development.

Karin E de Visser1, Lisa M Coussens.   

Abstract

The role of the immune system during cancer development is complex involving extensive reciprocal interactions between genetically altered cells, adaptive and innate immune cells, their soluble mediators and structural components present in the neoplastic microenvironment. Each stage of cancer development is regulated uniquely by the immune system; whereas full activation of adaptive immune cells at the tumor stage may result in eradication of malignant cells, chronic activation of innate immune cells at sites of premalignant growth may actually enhance tumor development. In addition, the balance between desirable antitumor immune responses and undesirable pro-tumor chronic inflammatory responses largely depends on the context in which a malignancy is developing. The following chapter focuses on the inflammatory components and processes engaged during cancer development and the impact of the inflammatory microenvironment.

Entities:  

Mesh:

Year:  2006        PMID: 16627962     DOI: 10.1159/000092969

Source DB:  PubMed          Journal:  Contrib Microbiol        ISSN: 1420-9519


  91 in total

1.  Transcriptional factor EB regulates macrophage polarization in the tumor microenvironment.

Authors:  Liang Fang; Johnie Hodge; Fatma Saaoud; Junfeng Wang; Stephen Iwanowycz; Yuzhen Wang; Yvonne Hui; Trent D Evans; Babak Razani; Daping Fan
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

Review 2.  Protein kinase CK2, an important regulator of the inflammatory response?

Authors:  Nishi N Singh; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

3.  Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma.

Authors:  Bi Cheng Zhang; Juan Gao; Jun Wang; Zhi Guo Rao; Bao Cheng Wang; Jian Fei Gao
Journal:  Med Oncol       Date:  2010-07-30       Impact factor: 3.064

4.  Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer.

Authors:  Angela M Jarrett; Meghan J Bloom; Wesley Godfrey; Anum K Syed; David A Ekrut; Lauren I Ehrlich; Thomas E Yankeelov; Anna G Sorace
Journal:  Math Med Biol       Date:  2019-09-02       Impact factor: 1.854

Review 5.  The reactive stroma microenvironment and prostate cancer progression.

Authors:  David A Barron; David R Rowley
Journal:  Endocr Relat Cancer       Date:  2012-10-30       Impact factor: 5.678

6.  Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted by U373 glioma cells.

Authors:  Rajshekhar A Kore; Edathara C Abraham
Journal:  Biochem Biophys Res Commun       Date:  2014-09-26       Impact factor: 3.575

7.  Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis.

Authors:  Lopamudra Das Roy; Latha B Pathangey; Teresa L Tinder; Jorge L Schettini; Helen E Gruber; Pinku Mukherjee
Journal:  Breast Cancer Res       Date:  2009-07-30       Impact factor: 6.466

8.  Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.

Authors:  Iris Helfrich; Inka Scheffrahn; Sönke Bartling; Joachim Weis; Verena von Felbert; Mark Middleton; Masahi Kato; Süleyman Ergün; Helmut G Augustin; Dirk Schadendorf
Journal:  J Exp Med       Date:  2010-03-01       Impact factor: 14.307

9.  Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung.

Authors:  Anna G Taranova; David Maldonado; Celine M Vachon; Elizabeth A Jacobsen; Hiam Abdala-Valencia; Michael P McGarry; Sergei I Ochkur; Cheryl A Protheroe; Alfred Doyle; Clive S Grant; Joan Cook-Mills; Lutz Birnbaumer; Nancy A Lee; James J Lee
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

10.  A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.

Authors:  Fabien Reyal; Martin H van Vliet; Nicola J Armstrong; Hugo M Horlings; Karin E de Visser; Marlen Kok; Andrew E Teschendorff; Stella Mook; Laura van 't Veer; Carlos Caldas; Remy J Salmon; Marc J van de Vijver; Lodewyk F A Wessels
Journal:  Breast Cancer Res       Date:  2008-11-13       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.